Notably, the tumor growth rate was markedly suppressed by the PBRM1 overexpression plasmid‐loaded nanomedicine, while it was significantly accelerated by the shPBRM1 plasmid‐loaded nanomedicine (Figure 4d). The gene discussed is PBRM1; the disease is neoplasm.